MUC1 (Mucin 1)
- Used for: Breast cancer, ovarian cancer, pancreatic cancer.
- Why it’s good: Overexpression of MUC1 is seen in many cancers, making it a broad biomarker.
- Limitation: It can be elevated in non-cancerous conditions as well.
Similar Posts
KRAS Mutations
KRAS mutations are among the most common oncogenic drivers in human cancers, notably in pancreatic, colorectal, and lung cancers. The KRAS gene encodes a protein that functions as a molecular switch, regulating cell growth and division. Mutations, particularly at codon 12 (such as G12D), impair the protein’s GTPase activity, leading to uncontrolled cellular proliferation. KRAS…
AFP (Alpha-Fetoprotein)
Alpha-Fetoprotein (AFP) is a well-established cancer biomarker with diverse clinical applications, especially in liver and germ cell tumors. Here’s a detailed summary of its biological role, diagnostic value, prognostic utility, and emerging therapeutic applications, based on recent studies: 🔬 What is AFP? AFP is a glycoprotein produced by the fetal liver and yolk sac. After…
PSA (Prostate-Specific Antigen)
Prostate-Specific Antigen (PSA) is a widely used cancer biomarker, particularly for prostate cancer (PCa). While it has transformed prostate cancer screening and monitoring, it also has notable limitations. Here’s a detailed breakdown based on current research: 🔍 What is PSA? PSA is a serine protease produced mainly by the prostate gland. It is highly organ-specific…